Allurion Technologies, Inc.

1.8500-0.02 (-1.07%)
Oct 29, 4:00:02 PM EDT · NYSE · ALUR · USD

Upcoming Earnings

Report date
≈ Nov 13, 2025 (in 14 days)

Key Stats

Market Cap
14.36M
P/E (TTM)
-
Basic EPS (TTM)
-10.13
Dividend Yield
0%

Recent Filings

About

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

CEO
Dr. Shantanu K. Gaur M.D.
IPO
3/29/2021
Employees
134
Sector
Healthcare
Industry
Medical Devices